Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -33.115\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1nc(Cl)c2c(n1)N(CC(N)=O)C(=O)CO2
b.) Br.CCCCn1c(=N)n(CC(=O)c2ccc([N+](=O)[O-])cc2)c2ccccc21
c.) Cc1ccc(S(=O)(=O)Cn2nnnc2C(C(C)C)N2CCN(c3nc4ccccc4s3)CC2)cc1
d.) CCc1ccc(C2=NN(CCC(=O)NC(C)CCc3ccccc3)C(=O)CC2)cc1
e.) CCOC(=O)c1c(C)[nH]c(C)c1C(=O)CN1C(=O)NC2(CCCCCC2)C1=O
Answer: b. Br.CCCCn1c(=N)n(CC(=O)c2ccc([N+](=O)[O-])cc2)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Br.CCCCn1c(=N)n(CC(=O)c2ccc([N+](=O)[O-])cc2)c2ccccc21
Br.CCCCn1c(=N)n(CC(=O)c2ccc([N+](=O)[O-])cc2)c2ccccc21
2-(3-butyl-2-iminobenzimidazol-1-yl)-1-(4-nitrophenyl)ethanone;hydrobromide